Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vulcan Materials
VMC
|
+$180M |
| 2 |
Walmart Inc
WMT
|
+$154M |
| 3 |
McDonald's
MCD
|
+$143M |
| 4 |
Hartford Financial Services
HIG
|
+$143M |
| 5 |
Citigroup
C
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$153M |
| 2 |
Advance Auto Parts
AAP
|
+$131M |
| 3 |
Wells Fargo
WFC
|
+$130M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$116M |
| 5 |
Abbott
ABT
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.64% |
| 2 | Consumer Discretionary | 12.28% |
| 3 | Healthcare | 9.19% |
| 4 | Energy | 8.04% |
| 5 | Technology | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRUB
1401
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $308K | ﹤0.01% |
4,688
-10,903
| -70% | -$805K |
|
|
KITE
1402
DELISTED
Kite Pharma, Inc.
KITE
| $306K | ﹤0.01% |
+3,900
| New | +$241K |
|
|
ZIXI
1403
DELISTED
Zix Corporation
ZIXI
| $305K | ﹤0.01% |
63,309
+36,496
| +136% | +$180K |
|
1404
KBR
KBR
$4.78B
| $302K | ﹤0.01% |
20,114
-229,886
| -92% | -$3.65M |
|
|
RARX
1405
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $302K | ﹤0.01% |
14,170
+590
| +4% | +$11.3K |
|
|
SPR
1406
DELISTED
Spirit AeroSystems
SPR
| $301K | ﹤0.01% |
5,200
-12,795
| -71% | -$748K |
|
1407
Kosmos Energy
KOS
$1.73B
| $299K | ﹤0.01% |
44,866
+25,297
| +129% | +$159K |
|
|
SCS
1408
DELISTED
Steelcase
SCS
| $297K | ﹤0.01% |
17,704
+3,403
| +24% | +$56.2K |
|
1409
CNO Financial Group
CNO
$5.03B
| $293K | ﹤0.01% |
+14,315
| New | +$287K |
|
1410
Bloomin' Brands
BLMN
$997M
| $289K | ﹤0.01% |
14,630
-1,813
| -11% | -$32.3K |
|
1411
Phibro Animal Health
PAHC
$1.47B
| $287K | ﹤0.01% |
+10,200
| New | +$288K |
|
1412
Interparfums
IPAR
$3.74B
| $285K | ﹤0.01% |
+7,800
| New | +$270K |
|
1413
Lennar Class B
LEN.B
$21.1B
| $285K | ﹤0.01% |
+7,313
| New | +$261K |
|
|
INVX
1414
Innovex International
INVX
$2.01B
| $284K | ﹤0.01% |
+5,205
| New | +$311K |
|
1415
Fair Isaac
FICO
$25.2B
| $281K | ﹤0.01% |
+2,183
| New | +$277K |
|
1416
OraSure Technologies
OSUR
$264M
| $278K | ﹤0.01% |
21,501
+2,690
| +14% | +$27.8K |
|
|
HRG
1417
DELISTED
HRG Group, Inc.
HRG
| $276K | ﹤0.01% |
+14,310
| New | +$251K |
|
1418
Cencora
COR
$61B
| $274K | ﹤0.01% |
3,100
-7,663
| -71% | -$673K |
|
|
OSG
1419
DELISTED
Overseas Shipholding Group Inc.
OSG
| $273K | ﹤0.01% |
70,708
+41,208
| +140% | +$194K |
|
|
PIR
1420
DELISTED
Pier 1 Imports, Inc.
PIR
| $272K | ﹤0.01% |
+1,898
| New | +$278K |
|
|
LHO
1421
DELISTED
LaSalle Hotel Properties
LHO
| $272K | ﹤0.01% |
9,400
+1,800
| +24% | +$53.5K |
|
1422
Alkermes
ALKS
$8.03B
| $269K | ﹤0.01% |
4,600
-213,600
| -98% | -$12.1M |
|
|
ZNGA
1423
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $268K | ﹤0.01% |
+94,168
| New | +$253K |
|
1424
Wolfspeed
WOLF
$1.22B
| $267K | ﹤0.01% |
+10,000
| New | +$272K |
|
1425
Teekay Tankers
TNK
$3.22B
| $266K | ﹤0.01% |
16,203
+2,464
| +18% | +$45.7K |
|
Similar funds
Dmitry Balyasny's Q1 2017 Portfolio in Review
As of Q1 2017, Dmitry Balyasny held 1,926 positions worth $21.4B, up 15% from $18.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dmitry Balyasny deployed $1.67B of net new capital in Q1 2017, opening 598 new positions and adding to 490 existing holdings. Its largest new stake was Citigroup: 2,292,111 shares worth $137M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $153M trimmed.
- Dmitry Balyasny's largest Q1 2017 buy was Citigroup: 2,292,111 shares worth $137M.
- Dmitry Balyasny added most to Vulcan Materials in Q1 2017, an estimated $180M increase.
- Dmitry Balyasny's biggest Q1 2017 reduction was Freeport-McMoran, cutting an estimated $153M.
- Dmitry Balyasny fully exited Coterra Energy in Q1 2017, selling an estimated $116M.
- Dmitry Balyasny's ten largest holdings make up 10% of its $21.4B portfolio in Q1 2017.
- Dmitry Balyasny opened 598 new positions and closed 369 in Q1 2017.
- Dmitry Balyasny's portfolio value rose 15% quarter-over-quarter to $21.4B.
Based on Balyasny Asset Management's 13F filing for Q1 2017, filed 15 May 2017.